tripeptidyl peptidase 1 stimulator (Weill Medical College of Cornell University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nametripeptidyl peptidase 1 stimulator (Weill Medical College of Cornell University)

Drug Alias NameFc-AAT (Omni)recombinant alpha-1 antitrypsin (Omni)recombinant alpha-1 antitrypsin (Omni)

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment

Mechanisms of ActionAlpha-1-antiproteinase stimulants

TargetsAlpha-1-antiproteinase

Therapy Area/IndicationsInflammationImmune System DiseasesMyocardial Infarction

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesOmni Bio Pharmaceutical Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesOmni Bio Pharmaceutical Inc

Active IndicationsN/A

Inactive IndicationsInflammationImmune System DiseasesMyocardial Infarction

Other Information

ATC CodeN/A